Works matching IS 10781552 AND DT 2023 AND VI 29 AND IP 5

Results: 33

Treating multiple myeloma in the era of new drugs: What is the right choice?

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1234, doi. 10.1177/10781552231176499

By:

Perego, Gianluca;
Paris, Laura;
Nozza, Silvia;
Stefanoni, Paola;
Franzin, Michela

Publication type:

Article

Clinical clerkship at an oncology hospital based on the curriculum of a clinical pharmacy program from a university belonging to low-middle-income country: Insights from a pharmacy program experience.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1227, doi. 10.1177/10781552231174784

By:

Pathak, Nabin;
Basyal, Bijaya

Publication type:

Article

Basic concepts of cancer genetics and receptor tyrosine kinase inhibition for pharmacists. A narrative review.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1187, doi. 10.1177/10781552231153814

By:

Orrico, Kathleen B.

Publication type:

Article

Alectinib-induced hemolytic anemia.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1251, doi. 10.1177/10781552221147840

By:

Lee, Chung-Shien;
Sullivan, Kevin

Publication type:

Article

Pharmacokinetic approach in therapeutic monitoring of antineoplastic drugs and the impact on pharmacoeconomics: A systematic review.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1218, doi. 10.1177/10781552231171827

By:

Barbosa, Islania Almeida Brandão;
Silva, Taiane Candeias da;
Souza, Monielly Vasconcelos Pereira de;
Pedreira, Lorena Argolo;
Godoy, Ana Leonor Pardo Campos

Publication type:

Article

Alectinib in a patient with ALK-positive non-small lung cancer unable to swallow capsules.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1283, doi. 10.1177/10781552231155374

By:

Ishiura, Yoshihisa;
Nomura, Shosaku;
Ishii, Yuka;
Imai, Kai;
Nakahama, Kahori;
Sawai, Yusuke;
Tamaki, Takeshi;
Shimizu, Toshiki;
Miyashita, Naoyuki;
Ito, Tomoki

Publication type:

Article

Widespread vitiligo and poliosis following ipilimumab–nivolumab combination therapy.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1278, doi. 10.1177/10781552231154460

By:

Nemovi, Khashayar;
Jamali, Arsia;
Matinpour, Keyan;
Dasanu, Constantin A

Publication type:

Article

Ribociclib-induced hepatotoxicity.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1275, doi. 10.1177/10781552231154009

By:

Er, Muhammed Muhiddin;
Araz, Murat;
Hendem, Engin;
Eryılmaz, Melek Karakurt;
Artaç, Mehmet

Publication type:

Article

Updates in the use of targeted therapies for the treatment of cholangiocarcinoma.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1206, doi. 10.1177/10781552231171079

By:

Lodl, Emma;
Ramnaraign, Brian;
Sahin, Ilyas;
Wheeler, Sarah

Publication type:

Article

The role of the pharmacist in the hospital discharge of cancer patients: an integrative review.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1196, doi. 10.1177/10781552231160678

By:

Mattos, Luciana Favoreto Vieira;
de Sousa, Ana Rosa Navegantes;
Teixeira, Jéssica Fernanda;
Costa, Mariana Fernandes;
de Castilho, Selma Rodrigues

Publication type:

Article

Atezolizumab induced new-onset type 1 diabetes mellitus.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1268, doi. 10.1177/10781552231151656

By:

de Carlos, Joaquín;
Zabalza, Lucia;
Garcia, Javier;
Marti, Miguel;
Ayarza-Marien, Xabier;
Yoldi, Jon

Publication type:

Article

Genetic variants found in paediatric oncology patients with severe chemotherapy-induced toxicity: A case series.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1237, doi. 10.1177/10781552221137302

By:

Bernsen, EC;
Hanff, LM;
Haveman, LM;
Tops, BBJ;
van der Lee, M;
Swen, JJ;
Huitema, ADR;
Diekstra, MHM

Publication type:

Article

Recurrent and atypical immune checkpoint inhibitor-induced pneumonitis.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1264, doi. 10.1177/10781552221150936

By:

Jeon, Won Jin;
Nguyen, Jasmine;
Castillo, Dani Ran;
Park, Kiwon;
Brothers, Joel;
Nguyen, Anthony;
Mirshahidi, Hamid

Publication type:

Article

Cycle-dependent eosinophilia due to adjuvant nivolumab for malignant melanoma.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1255, doi. 10.1177/10781552221148968

By:

Habibi, Shaghayegh;
Soliman, Abram;
Dasanu, Constantin A.

Publication type:

Article

Vincristine-induced ptosis in a leukemia patient treated with pyridoxine and pyridostigmine.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1271, doi. 10.1177/10781552231152414

By:

Johnson, Litha;
Johnson, Joji;
Philip, Sherin Mary;
Thirugnanam, Rajasekar

Publication type:

Article

Tamoxifen induced hands deformities.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1246, doi. 10.1177/10781552221147507

By:

Bendarkawi, Yasmine;
Cherif Chefchaouni, Ali;
Lkhoyaali, Sihame;
Bechar, Hafsa;
Boudina, Yassine;
Abercha, Youssef;
Belahcen, Mohammed Jaouad;
Rahali, Younes

Publication type:

Article

Comparison of different decision support software programs in perspective of potential drug–drug interactions in the oncology clinic.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1178, doi. 10.1177/10781552221104814

By:

Bektay, Muhammed Yunus;
Seker, Zehra;
Eke, Hatice Kubra;
Turk, Haci Mehmet;
Izzettin, Fikret Vehbi

Publication type:

Article

Nivolumab-induced autoimmune diabetes mellitus presenting as diabetic ketoacidosis in a patient with metastatic mucosal melanoma.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1259, doi. 10.1177/10781552221148973

By:

Goff, Catherine B;
Plaxe, Steven C;
White, Wendy;
Dasanu, Constantin A

Publication type:

Article

Switching to daratumumab SC from IV is safe and preferred by patients with multiple myeloma.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1172, doi. 10.1177/10781552221103551

By:

Mateos, Maria-Victoria;
Rigaudeau, Sophie;
Basu, Supratik;
Spicka, Ivan;
Schots, Rik;
Wrobel, Tomasz;
Cook, Gordon;
Beksac, Meral;
Gries, Katharine S;
Kudva, Anupa;
Tromp, Brenda;
Van Rampelbergh, Rian;
Pei, Huiling;
Wroblewski, Susan;
Carson, Robin;
Delioukina, Maria;
White, Darrell

Publication type:

Article

Management of immune-related hepatitis in patients being treated with checkpoint inhibitors for metastatic melanoma, a review and case series.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1163, doi. 10.1177/10781552221103548

By:

Tew, Alice;
Khoja, Leila;
Pallan, Lalit;
Steven, Neil

Publication type:

Article

Adherence to oral anti-cancer therapies in older patients is similar to that of younger patients.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1154, doi. 10.1177/10781552221103547

By:

Lory, Pauline;
Perche, Louise;
Blanc, Julie;
Fouquier, Bastian;
Giroux, Audrey;
Thomassin, Amélie;
Devaux, Madeline;
Renaudin, Amélie;
Di Martino, Cyril;
Quipourt, Valérie;
Bengrine-Lefèvre, Leïla;
Schmitt, Antonin

Publication type:

Article

Cyclin-dependent kinase 4/6 inhibitor treatment use in women treated for advanced breast cancer: Integrating ASCO/NCODA patient-centered standards in a community pharmacy.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1144, doi. 10.1177/10781552221102884

By:

Marineau, Alexandre;
St-Pierre, Catherine;
Lessard-Hurtubise, Roxanne;
David, Marie-Ève;
Adam, Jean-Philippe;
Chabot, Isabelle

Publication type:

Article

Associations of readiness for hospital discharge with symptoms and non-routine utilization of post-discharge services among cancer patients receiving oral chemotherapy at home: A prospective study.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1135, doi. 10.1177/10781552221100720

By:

Chen, Yongfeng;
Chen, Yanrong;
Qin, Ting;
Fu, Guifen;
Bai, Jinbing

Publication type:

Article

Monoclonal-induced cardiotoxicity in patients with non-Hodgkin's lymphoma and breast cancer: A retrospective study in an oncology clinic.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1125, doi. 10.1177/10781552221098426

By:

Silva, Paula Nogueira da;
Valente, Patrícia Marques Soares;
Castilho, Selma Rodrigues de

Publication type:

Article

Incidence of bleeding events in patients on concomitant tyrosine kinase inhibitors and selective serotonin reuptake inhibitors.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1119, doi. 10.1177/10781552221098044

By:

Venkataraman, Vinayak;
Bales, John R;
Signorelli, Jessie;
Hobbs, Gabriela S

Publication type:

Article

Adherence to practice guidelines for the management of febrile neutropenia in patients undergoing hematopoietic stem cell transplantation: An observational study in a referral center in Iran.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1112, doi. 10.1177/10781552221092158

By:

Ekhtiari Kolour, Seyedeh Reyhaneh;
Shahrami, Bita;
Kargar, Mona;
Taghvaye Masoumi, Hamidreza;
Amini, Shahideh;
Vaezi, Mohammad;
Hadjibabaie, Molouk;
Mohammadi, Mehdi;
Sadeghi, Kourosh

Publication type:

Article

Pharmacological profile and potential drug interactions in ovarian cancer hospitalized patients.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1103, doi. 10.1177/10781552221091298

By:

Badin, Rebeka Caribé;
Martins, Carolina Souza Machado;
Manaças, Liliane Rosa Alves

Publication type:

Article

Clinical utility of a regional precision medicine molecular tumor board and challenges to implementation.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1094, doi. 10.1177/10781552221091282

By:

Peh, Keng Hee;
Przybylski, Daniel J;
Fallon, Michael J;
Bergsbaken, Jason J;
Hutson, Paul R;
Yu, Menggang;
Deming, Dustin A;
Burkard, Mark E

Publication type:

Article

An investigation of the use of app technology to support clinical management of patients with chronic myeloid leukaemia (CML).

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1083, doi. 10.1177/10781552221090904

By:

Khadam, Saffiya;
Chu, Teresa;
Deekes, Nigel;
FitzGerald, David;
Preston, Andrea;
Duncan, Nick

Publication type:

Article

Health professionals' practice to care cytotoxic drug handling and associated factors: The case of university of gondar specialized hospital.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1075, doi. 10.1177/10781552221090200

By:

Simegn, Wudneh;
Dagnew, Baye;
Dagne, Henok

Publication type:

Article

International society of oncology pharmacy practitioners (ISOPP) position statement: The role of oncology pharmacy practitioners in immunotherapy treatment with immune checkpoint inhibitors for malignant conditions.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1065, doi. 10.1177/10781552221090199

By:

Walker, Andrew;
Chan, Alexandre;
Labra, Constanza Cortés;
de Lemos, Mario L.;
Geirnaert, Marc;
Albert-Marí, María Asunción;
Atik, Elif Aras;
Borlagdan, Jared;
Crespo, Andrea;
Danilak, Melanie;
Kandemir, Esin Aysel;
Lim, CheaXin;
Alabelewe, Ramatu Mas'ud;
Mutiara, Rina;
Tewthanom, Karunrat;
Yim, Barbara;
Nakashima, Lynne

Publication type:

Article

Pharmacists' practices and views regarding management of sexual health in patients with cancer.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1044, doi. 10.1177/10781552221089667

By:

Shivji, Alisha;
Danilak, Melanie;
Booker, Reanne;
Dersch-Mills, Deonne;
Ghosh, Sunita;
Fung, Katherine

Publication type:

Article

Physicochemical stability of PF-06439535 (bevacizumab-bvzr; Zirabev ®), a bevacizumab biosimilar, under extended in-use conditions.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1032, doi. 10.1177/10781552221088020

By:

Weiser, Sarah;
Burns, Chris;
Zartler, Edward R.

Publication type:

Article